about
The fate of chemoresistance in triple negative breast cancer (TNBC)Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancerThe MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.Lipofuscin accumulation and autophagy in glaucomatous human lamina cribrosa cells.Taxanes, microtubules and chemoresistant breast cancer.Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.Estrogen receptor beta and breast cancer.Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.Elevated expression and altered processing of fibulin-1 protein in human breast cancer.Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancerCENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancerRole of the progesterone receptor (PR) and the PR isoforms in breast cancer.Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitroAlpha T-catenin (CTNNA3): a gene in the hand is worth two in the nest.A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissue.Overcoming multiple myeloma drug resistance in the era of cancer 'omics'.Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.MAD2 downregulation in hypoxia is independent of promoter hypermethylation.Generation of an epigenetic signature by chronic hypoxia in prostate cells.Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalization.Small interfering RNAs induce macrophage migration inhibitory factor production and proliferation in breast cancer cells via a double-stranded RNA-dependent protein kinase-dependent mechanism.Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.Epigenetic effect of cadmium on global de novo DNA hypomethylation in the cadmium-induced ventral body wall defect (VBWD) in the chick model.Estrogen receptor alpha and beta profiling in human breast cancer.Anxiety is associated with higher levels of global DNA methylation and altered expression of epigenetic and interleukin-6 genes.Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells.The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses.Biallelic expression of the IGF2 gene in human breast disease.Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancer.5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer.Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype.BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer.miR-433 overexpression attenuates the spindle assembly checkpoint response to paclitaxel.Resident bacteria in breast cancer tissue: pathogenic agents or harmless commensals?Erratum: Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitroUrinary insulin-like growth factor 2 identifies the presence of urothelial carcinoma of the bladderEnsuring we involve seldom heard voices in supporting the Data Protection Act 2018 (Section 36(2)) (Health Research) Regulations 2018Irish association for cancer researchCommentary on paper: 5-Aza-2′-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating β-galactoside:α2,3-sialyltransferase 6 gene (Chachadi et al.)Targeting Proteotoxic Stress in Cancer: A Review of the Role that Protein Quality Control Pathways Play in Oncogenesis
P50
Q26775232-97581199-E7BB-4883-90C7-DBFDB080D082Q28218774-F7D25908-885B-4861-8FA1-E331851907E4Q33825555-C4510193-0655-431A-89B4-B44C517E65DBQ34695483-F3503AA5-0D5A-4E8F-A144-08BC9ED2D286Q34722919-DE8C1A36-18C6-4A58-9BB0-1DC1414111EEQ35602152-7A75AD7E-B900-439E-81BD-8F4383191F71Q35937358-37BBCC89-6273-4F75-BEB6-E0A0226F4E41Q36080896-FF8ADFB0-15DA-465A-B553-0233469C8381Q36648848-EBAA417E-DB1E-409B-BA47-4CF663D1704BQ36670959-CEE1809C-58B5-4923-A274-064EAB4F19BDQ37149363-FD640C04-5D81-42E1-A2D9-D756E1CAF8BFQ37186733-12F6DDAF-F834-4A18-92C3-3C438E804782Q37457681-03192D33-B625-41FD-8D92-6A9205BCC600Q37877619-E4EDF5A0-0187-4E55-8780-492BBF55A887Q38441004-9A083A19-FEE2-473D-A91F-807ECE8C30F3Q38671390-AE8B593B-2DFD-45E8-8A70-8BF937A6B2CAQ38968841-7E769E7A-103A-47A5-A273-36E4E10EF1F7Q39672956-EA9A3BC1-BC19-4D00-8FF2-E6907ECAFE62Q39827986-48CF040A-60AA-4DF8-9DF4-11A876041748Q39921965-A3BBB069-50E2-41CD-A647-20E8913A2197Q39980611-2AABB18A-97D9-4203-9DE8-C0C52224EBD3Q40052411-AA1A5C06-B9E0-470A-9042-A64B2E7B1753Q42753922-B303370B-0339-4BDB-9DD2-21FF4E683153Q44890332-4A4C554D-3580-41A7-A739-E673C62F7CDEQ46043530-01533CA9-0972-4F74-A3D6-0CE2A9C8F064Q47095396-25A028FF-6292-4C32-8B5B-9AF756EFD8BCQ47165015-2B9976F9-9A2A-4D83-8E66-B57F9FFC3760Q52521577-D49421B2-370A-48A0-BFDA-418CFDA8B213Q53053707-1480DE62-E977-4420-8FBD-D9EF2BCF3064Q53278868-DF9D5DCF-FF2A-4ED3-B4E3-F6CC4C6FC0A8Q54495572-11A35997-8226-49A3-85C3-352290F2982EQ55029136-674A0E38-90E4-4AB6-B136-3FAA7F2ECAA3Q55561830-15E265D3-9241-4C10-B166-25CEC60E434CQ58557535-94EC32D9-BDDB-4A6F-955E-F5FE0B4C9D58Q58825364-8F49FCE1-DCBB-4E4B-BC41-1BCA0F5D73DEQ58825390-EE27797E-20F1-43AD-9E9B-2D780B335139Q58999568-1A9FEEB9-BE6D-49BB-8E7E-A2996932596AQ60188717-5FC4BB1E-3A99-410A-BF75-3AD84068BBEEQ60678379-4AFEB207-4892-4304-B5F6-C1CAC7393280Q61799039-728FDFB6-3A49-4A25-901E-0E1881C5F436
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
A McCann
@ast
A McCann
@en
A McCann
@es
A McCann
@nl
type
label
A McCann
@ast
A McCann
@en
A McCann
@es
A McCann
@nl
altLabel
Amanda McCann
@en
prefLabel
A McCann
@ast
A McCann
@en
A McCann
@es
A McCann
@nl
P106
P1153
7003674061
P31
P496
0000-0003-1911-3307